Literature DB >> 19225543

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.

Mary G Boy, Cunshan Wang, Bethanie E Wilkinson, Vincent Fung-Sing Chow, Alan T Clucas, James G Krueger, Anderson S Gaweco, Samuel H Zwillich, Paul S Changelian, Gary Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19225543     DOI： 10.1038/jid.2009.25

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  41 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  Psoriasis: from bed to bench and back.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

Review 3.  Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.

Authors:  Apostolos Kontzias; Alexander Kotlyar; Arian Laurence; Paul Changelian; John J O'Shea
Journal:  Curr Opin Pharmacol       Date:  2012-07-19       Impact factor: 5.547

4.  Risk of tuberculosis reactivation with tofacitinib (CP-690550).

Authors:  Mamoudou Maiga; Shichun Lun; Haidan Guo; Kathryn Winglee; Nicole C Ammerman; William R Bishai
Journal:  J Infect Dis       Date:  2012-04-03       Impact factor: 5.226

5.  Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.

Authors:  Brittany G Craiglow; Brett A King
Journal:  J Invest Dermatol       Date:  2014-06-18       Impact factor: 8.551

Review 6.  Biological therapy for ulcerative colitis: an update.

Authors:  Geom Seog Seo; Soo-Cheon Chae
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

7.  Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

Authors:  Julian Mackay-Wiggan; Ali Jabbari; Nhan Nguyen; Jane E Cerise; Charlotte Clark; Grace Ulerio; Megan Furniss; Roger Vaughan; Angela M Christiano; Raphael Clynes
Journal:  JCI Insight       Date:  2016-09-22

Review 8.  Janus kinase inhibitors in autoimmune diseases.

Authors:  John J O'Shea; Apostolos Kontzias; Kunihiro Yamaoka; Yoshiya Tanaka; Arian Laurence
Journal:  Ann Rheum Dis       Date:  2013-04       Impact factor: 19.103

9.  Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis.

Authors:  Debra M Meyer; Michael I Jesson; Xiong Li; Mollisa M Elrick; Christie L Funckes-Shippy; James D Warner; Cindy J Gross; Martin E Dowty; Shashi K Ramaiah; Jeffrey L Hirsch; Matthew J Saabye; Jennifer L Barks; Nandini Kishore; Dale L Morris
Journal:  J Inflamm (Lond)       Date:  2010-08-11       Impact factor: 4.981

10.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.